125 related articles for article (PubMed ID: 32902238)
1. Aberrant Expression of Cancer-Testis Antigen FBXO39 in Breast Cancer and its Clinical Significance.
Liu YC; Yan S; Liu DM; Pei DX; Li YW
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902238
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.
Cui Z; Chen Y; Hu M; Lin Y; Zhang S; Kong L; Chen Y
Clin Chim Acta; 2020 Apr; 503():203-209. PubMed ID: 31794764
[TBL] [Abstract][Full Text] [Related]
3. FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma.
Yang Y; Zhao Y; Sun G; Zuo S; Chai J; Xu T; Liu J; Li L; Song J; Qian S; Kang Y; Sui F; Li M; Jia Q
Pathol Res Pract; 2022 Oct; 238():154090. PubMed ID: 36049441
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Lin Y; Zhou X; Peng W; Wu J; Wu X; Chen Y; Cui Z
BMC Cancer; 2021 Sep; 21(1):1062. PubMed ID: 34565331
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of FBXO39 and ETS-1 but not BMI-1 in Iranian Colorectal Cancer Patients.
Motalebzadeh J; Shabani S; Rezayati S; Shakournia N; Mirzaei R; Mahjoubi B; Hoseini K; Mahjoubi F
Asian Pac J Cancer Prev; 2018 May; 19(5):1357-1362. PubMed ID: 29802700
[TBL] [Abstract][Full Text] [Related]
6. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
[TBL] [Abstract][Full Text] [Related]
7. Significance of cancer testis-associated antigens (
Ramadan RA; Morsy H; Samir M; Shamseya M; Shalaby M; El-Attar EA
Indian J Cancer; 2022; 59(3):394-401. PubMed ID: 34380828
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
9. The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma.
Wu J; Yao F; Li Y; Zhao Z; Liu J; Xu T; Chai J; Yang Y; Song J; Tian C; Jia Q; Li M; Li L
Pathol Res Pract; 2022 Nov; 239():154168. PubMed ID: 36244247
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma.
Peng W; Chen J; Xiao Y; Su G; Chen Y; Cui Z
Front Oncol; 2022; 12():912624. PubMed ID: 35814471
[TBL] [Abstract][Full Text] [Related]
11. High serum exosomal long non-coding RNA DANCR expression confers poor prognosis in patients with breast cancer.
Shi W; Jin X; Wang Y; Zhang Q; Yang L
J Clin Lab Anal; 2022 Mar; 36(3):e24186. PubMed ID: 35150011
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.
Seifi-Alan M; Shamsi R; Ghafouri-Fard S; Mirfakhraie R; Zare-Abdollahi D; Movafagh A; Modarressi MH; Kazemi G; Geranpayeh L; Najafi-Ashtiani M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6625-9. PubMed ID: 24377578
[TBL] [Abstract][Full Text] [Related]
13. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
Wang J; Yang K; Yuan W; Gao Z
Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
[TBL] [Abstract][Full Text] [Related]
14. Cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in lung adenocarcinoma.
Gan Y; Kang Y; Zhong R; You J; Chen J; Li L; Chen J; Chen L
Sci Rep; 2024 Mar; 14(1):7573. PubMed ID: 38555374
[TBL] [Abstract][Full Text] [Related]
15. Serum Exosomal miR-17-5p as a Promising Biomarker Diagnostic Biomarker for Breast Cancer.
Lv S; Wang Y; Xu W; Dong X
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902214
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
Li YW; Li L
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
[No Abstract] [Full Text] [Related]
17. Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer.
Dong Z; Sun X; Xu J; Han X; Xing Z; Wang D; Ge J; Meng L; Xu X
Med Sci Monit; 2019 Oct; 25():7770-7783. PubMed ID: 31619663
[TBL] [Abstract][Full Text] [Related]
18. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
20. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
